These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3457646)
1. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells. Streeter DG; Johl JS; Gordon GR; Peters JH Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646 [TBL] [Abstract][Full Text] [Related]
2. Comparative cytotoxicities of various morpholinyl anthracyclines. Streeter DG; Taylor DL; Acton EM; Peters JH Cancer Chemother Pharmacol; 1985; 14(2):160-4. PubMed ID: 3971481 [TBL] [Abstract][Full Text] [Related]
3. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
4. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells. Krishan A; Sauerteig A; Gordon K; Swinkin C Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340 [TBL] [Abstract][Full Text] [Related]
7. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Inaba M; Kobayashi H; Sakurai Y; Johnson RK Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418 [TBL] [Abstract][Full Text] [Related]
8. Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180. Pradhan SG; Chitnis MP; Basrur VS; Tantri SK Eur J Cancer Clin Oncol; 1987 Apr; 23(4):437-42. PubMed ID: 3609108 [TBL] [Abstract][Full Text] [Related]
9. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells. Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108 [TBL] [Abstract][Full Text] [Related]
10. Exploring multidrug resistance using rhodamine 123. Kessel D Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells. Parekh H; Chitnis M Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755 [TBL] [Abstract][Full Text] [Related]
12. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695 [TBL] [Abstract][Full Text] [Related]
13. Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line. Bose R; Lam HY Cancer Chemother Pharmacol; 1988; 21(1):14-8. PubMed ID: 3342461 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210 [TBL] [Abstract][Full Text] [Related]
15. Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase alpha and RNA polymerase II of chicken leukemia cells. Chuang LF; Chuang RY; Acton EM; Israel M; Yu M J Pharmacol Exp Ther; 1987 Jul; 242(1):372-7. PubMed ID: 2441029 [TBL] [Abstract][Full Text] [Related]
16. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells. Adwankar MK; Chitnis MP Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178 [TBL] [Abstract][Full Text] [Related]
17. Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro. Wassermann K; Zwelling LA; Mullins TD; Silberman LE; Andersson BS; Bakic M; Acton EM; Newman RA Cancer Res; 1986 Aug; 46(8):4041-6. PubMed ID: 3731072 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related]
19. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines. Kunimoto S; Miura K; Umezawa K; Xu CZ; Masuda T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1984 Dec; 37(12):1697-702. PubMed ID: 6526737 [TBL] [Abstract][Full Text] [Related]